Citadel Advisors’s Ibere Pharmaceuticals Units IBER.U Stock Holding History
Bought
Maintained
Sold
Other funds holding IBER.U
Citadel Advisors's IBER.U Position: Q3 2021 in Review
Citadel Advisors sold out of Ibere Pharmaceuticals Units (IBER.U) in Q3 2021, closing a stake of 227,788 shares — an estimated $2.29M sold.
Citadel Advisors first reported a position in IBER.U in Q1 2021 and held it in 2 quarters. The position peaked at $7.64M in Q1 2021. 27 funds tracked by Wall St. Rank hold IBER.U as of Q3 2021.
- Citadel Advisors reported no remaining Ibere Pharmaceuticals Units position as of Q3 2021 after selling out during the quarter.
- Citadel Advisors sold 227,788 Ibere Pharmaceuticals Units shares in Q3 2021, an estimated $2.29M.
- Citadel Advisors first reported a position in Ibere Pharmaceuticals Units in Q1 2021 and held it in 2 quarters.
- Citadel Advisors's Ibere Pharmaceuticals Units position peaked at $7.64M in Q1 2021.
- 27 funds tracked by Wall St. Rank held Ibere Pharmaceuticals Units as of Q3 2021.
Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.